ABEONA THERAPEUTICS INC. ABEO Income Statement

Abeona therapeutics inc. (ABEO)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues:
Revenues
-	-	-	-	-	-	1,709	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Expenses:
Total revenues
-	-	-	0	-	-	-	276	531	-	219	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total revenues
-	-	-	-	-	-	-	-	-	-	-	217	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foundation grants
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	30	0	0
Royalties
-	-	-	-	-	-	-	-	-	-	-	-	35	-	33	64	84	65	134	132	107	84	84	97	62	30	45	3	0	29	28	15	21	25	23	21	20	20	18
Product sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-13	0	380	1,162	915	781	615	554	402	82	42	13	0	0
License revenues
-	-	-	-	-	-	-	-	-	-	-	-	151	-	151	150	151	150	151	150	151	150	152	150	146	145	144	84	62	62	62	60	1,262	71	936	87	87	107	87
Total revenues
-	-	-	-	-	-	-	-	-	-	-	-	186	-	184	214	235	215	285	282	258	234	236	247	208	162	189	467	1,224	1,006	871	690	1,837	498	1,041	150	150	127	105
Research and development
6,818	9,605	10,917	16,307	11,737	9,470	13,150	7,916	8,162	5,706	3,277	5,808	2,198	3,037	2,745	3,018	1,855	2,071	1,581	610	453	35	73	81	144	128	236	197	323	298	308	654	750	650	906	903	1,120	1,199	733
General and administrative
6,412	4,734	4,700	5,612	5,659	7,631	4,970	4,627	2,878	3,113	2,166	2,642	3,022	2,803	2,391	3,730	4,366	4,247	4,717	3,667	1,689	657	795	868	1,392	-	-	-	-	-	-	-	-	-	1,802	1,404	1,026	1,165	1,253
Product costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	7	53	65	66	79	63	59	-42	61	37	92	0	0
Selling, general and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	717	642	2,137	1,338	1,533	1,422	1,406	1,663	-	-	-	-	-	-
Depreciation and amortization
2,065	2,072	2,032	2,057	1,658	1,391	505	290	174	146	138	207	250	248	222	181	174	150	151	132	118	9	1	1	0	1	0	1	1	328	18	19	54	57	56	59	61	59	59
Licensed technology impairment charge
32,916	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total expenses
48,211	-	17,649	-	19,054	-	18,625	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total expenses
-	-	-	23,976	-	-	-	12,833	11,214	-	5,581	8,657	5,470	6,088	5,358	6,929	6,395	6,468	6,449	4,409	2,260	701	869	950	1,536	846	885	2,388	1,727	2,225	1,827	2,142	2,526	2,188	2,825	2,403	2,299	2,423	2,045
Loss from operations
-48,211	-16,411	-17,649	-23,976	-19,054	-18,010	-16,916	-12,557	-10,683	-8,750	-5,362	-8,440	-5,284	-5,832	-5,174	-6,715	-6,160	-6,253	-6,164	-4,127	-2,002	-467	-633	-703	-1,328	-684	-696	-1,921	-503	-1,219	-956	-1,452	-689	-1,690	-1,784	-2,253	-2,149	-	-
Interest and miscellaneous income
652	-	277	-	499	-	500	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
600	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest and other expense
-	-	-	-	-	-	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,296	-1,940
Interest and miscellaneous income
-	-	-	52	-	-	-	317	156	-	21	164	39	-1,168	2,551	13	618	3,915	92	16	3	0	11	26	8	36	46	75	94	130	111	0	1	43	1,283	3	5	38	512
Interest and other expense
-	-	-	0	-	-	-	3	3	-	2	3	2	2	1	1	2	-	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest and other expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	176	147	137	122	97	96	43	43	84	186	169	169	203	237	356	167	152	143
Warrant extension expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	2,316	0	0	0	0	-	-
Gain on change in fair value of derivative-warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	131	168	219	-247	0	64	431	741	-	-	-	-	-	-
Loss on change in fair value of derivative-preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-11,300	-700	-11,693	583	-461	421	3,270	4,780	21,000	-13,900	-9,410	-2,460	-	-	-	-	-	-
Gain on change in fair value of derivative-warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,138	939	1,235	146	3,361
Loss on change in fair value of derivative - preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50	-403	823	10,455	0
Total non operating income (expense)
-	-	-	-	-	-	-	-	-	-	19	161	37	-	2,550	12	616	3,913	91	14	2	-11,476	-836	-11,804	469	-391	539	3,521	4,584	21,046	-13,911	-9,148	-4,203	1,988	2,134	989	250	-10,423	3,730
Net loss
-48,159	-16,431	-17,372	-23,924	-18,555	-17,479	-16,419	-12,243	-10,530	-8,450	-5,343	-8,279	-5,247	-7,002	-2,624	-6,703	-5,544	-2,340	-6,073	-4,113	-2,000	-11,943	-1,469	-12,507	-859	-1,075	-157	1,600	4,081	19,827	-14,867	-10,600	-4,892	281	350	-1,264	-1,899	-12,719	1,790
Less preferred stock dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	684	740	726	725	696	742	733	727	676	444	439	440	447	447	442	438	452	446
Net loss allocable to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12,627	-2,209	-13,233	-1,584	-1,771	-899	867	3,354	19,151	-15,311	-11,039	-5,332	-166	-97	-1,706	-2,337	-13,171	1,344
Basic and diluted loss per common share
-0.52	-0.30	-0.35	-0.49	-0.39	-0.36	-0.34	-0.26	-0.22	-0.19	-0.13	-0.21	-0.13	-0.19	-0.08	-0.20	-0.17	-0.08	-0.19	-0.16	-0.10	17.21	-4.15	-25.26	-3.06	-	-	-	-	-	-	-	-	-	0.00	-0.09	-	-0.83	-
Weighted average number of common shares outstanding - basic and diluted
92,639	54,718	49,721	48,961	47,948	47,944	47,794	47,303	47,060	45,643	40,377	40,270	40,254	37,919	33,274	32,784	32,743	32,922	31,787	25,695	19,983	6,197	532	523	517	-	-	-	-	-	-	-	-	-	19,503	19,387	-	-	-
Other comprehensive income/(loss):
Change in unrealized gains related to available-for-sale debt securities
386	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive loss
-47,773	-	-	-	-18,555	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.67	-1.77	0.03	0.14	0.79	-0.63	-0.46	-0.22	-	-	-	-0.12	-	0.09
Diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.65	-1.77	0.03	0.13	0.79	-0.63	-0.46	-0.22	-	-	-	-0.12	-	0.07
Basic (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-48,401	508	25,111	24,800	24,235	24,173	24,160	24,145	-	-	-	19,241	-	15,460
Diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-49,096	508	25,469	25,156	24,235	24,173	24,160	24,145	-	-	-	19,241	-	27,937
Weighted average basic and diluted common shares outstanding (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15,774	-
Foundation Revenues [Member]
Total revenues
-	-	-	-	-	-	1,687	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Royalties [Member]
Total revenues
-	-	-	-	-	-	22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foundation revenues
Total revenues
-	-	-	0	-	369	-	259	481	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License revenues [Member]
Total revenues
-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Royalties
Total revenues
-	-	-	0	-	113	-	17	50	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-